🔗 Read more: bit.ly/ONCOnews15D-01
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
Latest posts tagged with #CancerUpdates on Bluesky
🔗 Read more: bit.ly/ONCOnews15D-01
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
🔗 Read more: bit.ly/ONCOnews12D-01
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
🔗 Read more: bit.ly/ONCOnews11D-04
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
🔗 Read more: bit.ly/ONCOnews11D-05
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
HER2-targeted therapy is showing real promise in rare bile duct cancers. Early results hint at a powerful new option for patients who’ve had far too few. Hope finally breaking through. #TCSC #CancerResearch #Oncology #MedicalNews #CancerUpdates #HealthBreakthrough
www.mdanderson.org/newsroom/res...
🔗 Read more: bit.ly/ONCOnews21N-4
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #NSCLC
🔗 Read more: bit.ly/ONCOnews21N-3
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #Hematology #DrugApproval
🔗 Read more: bit.ly/ONCOnews21N-2
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #NeuroOncology
🔗 Read more: bit.ly/ONCOnews21N-1
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval
🚨FDA Approval Alert!
✅ FDA grants full approval to Amgen's IMDELLTRA® (tarlatamab-dlle) in extensive stage small cell lung cancer (ES-SCLC).
🎯 Phase 3 DeLLphi-304 shows 40% reduction in risk of death vs chemo.
🔗 Read more: bit.ly/ONCOnews20N3
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates
🔗 Read more: bit.ly/ONCOnews20N-2
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #LymphomaTreatment
🔗 Read more: bit.ly/ONCOnews19N-1
#ONCOnews #OncoAlert #OncEd #FDAApproval #Oncology #Lymphoma #CancerUpdates
🔗 Read more: bit.ly/ONCOnews19O-4
#ONCOnews #OncoAlert #OncEd #ESMO2025 #Oncology #BreastCancer #CancerUpdates
💫 #ONCOnews💫
🚨BREAKING: HUTCHMED’s ORPATHYS® (savolitinib) + TAGRISSO® (osimertinib) combo approved in China for lung cancer patients with MET amplification after progression on first-line EGFR inhibitor therapy
🔗 Read more: bit.ly/ONCOnews1JU-2
#OncoAlert #OncEd #LungCancer #CancerUpdates
💫#ONCOnews💫
🚨BREAKING: Patritumab Deruxtecan BLA Withdrawn!
📉The biologics license application for patients with previously treated EGFR-mutated advanced/metastatic NSCLC has been voluntarily withdrawn.
🔗 Read more: bit.ly/ONCOnews30M-1
#OncoAlert #OncEd #LungCancer #CancerUpdates
#LymphomaResearch #FightingCancer #CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
#CancerAdvocacy #LymphomaSupport #BloodCancer #LymphomaResearch #FightingCancer #CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
#CancerAdvocacy #LymphomaSupport #BloodCancer #LymphomaResearch #FightingCancer #CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
Thrilled to speak this Thursday at the @TotalHealthConf Lung/GI #CancerUpdates
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
#CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
#CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
#CancerAdvocacy
#LymphomaSupport
#BloodCancer
#LymphomaResearch
#FightingCancer
#CancerSurvivorship
#LivingWithLymphoma
#HodgkinsCommunity
#CancerUpdates
#LymphomaStories
#CancerWarrior
#LymphomaCare
#HodgkinsSurvivor
#TogetherWeFight
#CancerAdvocacy
#LymphomaSupport
#BloodCancer
#LymphomaResearch
#FightingCancer
#CancerSurvivorship
#LivingWithLymphoma
#HodgkinsCommunity
#CancerUpdates
#LymphomaStories
#CancerWarrior
#LymphomaCare
#HodgkinsSurvivor
#TogetherWeFight
#CancerAdvocacy
#LymphomaSupport
#BloodCancer
#LymphomaResearch
#FightingCancer
#CancerSurvivorship
#LivingWithLymphoma
#HodgkinsCommunity
#CancerUpdates
#LymphomaStories
#CancerWarrior
#LymphomaCare
#HodgkinsSurvivor
#TogetherWeFight
#CancerAdvocacy #LymphomaSupport #BloodCancer #LymphomaResearch #FightingCancer #CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
#CancerAdvocacy #LymphomaSupport #BloodCancer #LymphomaResearch #FightingCancer #CancerSurvivorship #LivingWithLymphoma #HodgkinsCommunity #CancerUpdates #LymphomaStories #CancerWarrior #LymphomaCare #HodgkinsSurvivor #TogetherWeFight
1/2: Big news from the San Antonio Breast Cancer Symposium: Some early-stage breast cancer patients may safely skip lymph node removal without compromising outcomes. This could mean fewer side effects and better quality of life. #BreastCancer #CancerUpdates
apnews.com/article/brea...